N-acetyl-d-glucosamine composition with anti-tumor efficacy and application thereof

By combining N-acetyl-D-glucosamine with Rakicidin A in a specific ratio to form a synergistic composition, the problem of the limited anti-tumor effect of N-acetyl-D-glucosamine is solved, and effective treatment of tumors and hyperuricemia is achieved.

CN122398993APending Publication Date: 2026-07-17LIAONING TAIYANG PHARMA TECH DEV
View PDF 1 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
LIAONING TAIYANG PHARMA TECH DEV
Filing Date
2026-05-25
Publication Date
2026-07-17

AI Technical Summary

Technical Problem

The existing N-acetyl-D-glucosamine has limited anti-tumor effects, and there is a lack of effective multi-component compound formulations to improve its application scope and efficacy.

Method used

N-acetyl-D-glucosamine and Rakicidin A are combined in a specific mass ratio to form a composition with synergistic effects, which can be used to prepare anti-tumor drugs and drugs for treating hyperuricemia.

Benefits of technology

It significantly improved antitumor activity and showed a marked uric acid-lowering effect in a hyperuricemia model, thus expanding the drug's applicability.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_4
    Figure SMS_4
  • Figure SMS_6
    Figure SMS_6
Patent Text Reader

Abstract

本发明涉及医药及保健品技术领域，尤其涉及一种具有抗肿瘤功效的N‑乙酰‑D‑氨基葡萄糖组合物及其应用。经体外动物抗肿瘤实验表明，本发明提供的N‑乙酰‑D‑氨基葡萄糖组合物能够显著减小大鼠模型中的肿瘤体积，为肿瘤患者的临床治疗提供了一种新途径，具有广泛应用前景。
Need to check novelty before this filing date? Find Prior Art